© 1988 by Biometrika Trust
Two-stage selection and testing designs for comparative clinical trials
Department of Statistics/Computer & Information Systems, George Washington University Washington, D.C. 20892, U.S.A.
National Cancer Institute Bethesda, Maryland 20892, U.S.A.
A two-stage design which selects the best of several experimental treatments and compares it to a standard control is proposed. The design allows early termination with acceptance of the global null hypothesis. Optimal sample size and cut-off parameters are obtained by minimizing expected total sample size for fixed significance level and power.
Key Words: Clinical trial Expected sample size Optimal design Selection Two-stage design
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Zheng and H. K. T. Ng Genetic model selection in two-phase analysis for case-control association studies Biostat., July 1, 2008; 9(3): 391 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Estey and P. F. Thall New designs for phase 2 clinical trials Blood, July 15, 2003; 102(2): 442 - 448. [Abstract] [Full Text] [PDF] |
||||

